ImmunoGen Inc.

(IMGN)

By |

Profile

Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.

Contact Information

Website: www.immunogen.com
Main Phone: +1 781 895-0600
Address: 830 Winter Street
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02451

Issuer Information

Exchange: NGS
Employees: 317
NAICS: Pharmaceutical P
$ 1.91 $ 0.14 (7.63%)
Last Price 1.91 Change $ 0.14 Change % 7.63 Tick N/A
Bid 1.90 Bid Size 1,800.00 Ask 1.91 Ask Size 5,500.00
Open 1.78 High 1.94 Low 1.78 Prev Close 1.77
Last Trade Volume 635,777 52 Wk Hi 14.10 52 Wk Low 1.51
Market Cap 166.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 87,301,341.00 EPS (TTM) -1.79 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 35
Number of Buys 1 20
Number of Sells 0 15
Net Activity 27085 55935
Last 10 Buys Shares
Dean Jonathan Mitchell 1,000
Mark A. Goldberg 1,000
Last 10 Sell Shares
John M. Lambert 1,000
Richard J. Gregory 1,000
John M. Lambert 1,000
Daniel M. Junius 1,000
Daniel M. Junius 1,000
John M. Lambert 1,000
Charles Morris 1,000
Daniel M. Junius 1,000
John M. Lambert 1,000
Daniel M. Junius 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 15 9
Low Target Price Estimate 2.5 2.5 5 2.5
Mean Target Price Estimate 6.33 6.14 9.36 5.9
Standard Deviation 2.4 2.25 3.47 2.41
Date of Most Recent Estimate 08/08/16 08/08/16 07/18/16 08/08/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 3 3
Moderate Buy 0 0 0 0
Hold 4 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.61 2.66 2.48 2.48